SEC Filings

SEC Filings

Filing date Form Description View
4 Statement of changes in beneficial ownership of securities View HTML
SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
8-K Report of unscheduled material events or corporate event View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
424B5 Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 View HTML
8-K Report of unscheduled material events or corporate event View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
3 Initial filing by director officer or owner of more than ten percent View HTML
4 Statement of changes in beneficial ownership of securities View HTML
SC 13G/A An amendment to the SC 13G filing View HTML
8-K Report of unscheduled material events or corporate event View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q Quarterly report which provides a continuing view of a company's financial position View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

© 2007 - 2026   aTyr Pharma.   Legal   Privacy Policy